The Centers for Medicare and Medicaid Services (CMS) has accepted EBR’s WiSE CRT system into the highly selective ...

EBR Systems is girding for US FDA approval of its novel heart lead in April and commercialisation by the end of the year.

Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...

Biventricular pacing is an excellent option for certain patients with advanced HF. Also known as “cardiac resynchronization therapy,” biventricular pacing has been shown to improve HF symptoms ...

Antitachycardia pacing (ATP) refers to the use of pacing stimulation techniques for termination of tachyarrhythmias. Such techniques can be automatically applied using implantable cardioverter ...

Little is known about the long-term pacing and mortality outcomes and the temporal trends of these patients. Methods: We examined 6,268 consecutive patients who underwent cardiac surgery at the ...

Multiple societies endorsed the new appropriate-use criteria for implantable cardioverter defibrillators, cardiac ...

EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:EBR) ) has issued an update.